Clinical Trials Logo

Syndrome clinical trials

View clinical trials related to Syndrome.

Filter by:

NCT ID: NCT00932841 Terminated - Clinical trials for Irritable Bowel Syndrome

The Use of VSL#3 in Irritable Bowel Syndrome in Children

VSL#3
Start date: January 2008
Phase: Phase 1
Study type: Interventional

The goal of this study is to determine whether the oral administration of the probiotic VSL#3 under randomized, placebo-controlled conditions will improve symptoms of irritable bowel syndrome in children, safely.

NCT ID: NCT00932100 Completed - Clinical trials for Acute Coronary Syndrome (ACS)

A Study Assessing the REG1 Anticoagulation System Compared Heparin in Subjects With Acute Coronary Syndrome

RADAR
Start date: July 2009
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of the REG1 anticoagulation System in Acute Coronary Syndrome (ACS) patients undergoing cardiac catheterization.

NCT ID: NCT00931502 Completed - Clinical trials for Acute Coronary Syndrome

Stent Thrombosis In Acute Coronary Syndromes

Start date: April 2008
Phase: N/A
Study type: Observational

The purpose of this study is to better understand what treatment methods result in the best outcomes for patients who have heart attacks due to blood clots forming within stents.

NCT ID: NCT00931294 Completed - Clinical trials for Irritable Bowel Syndrome

Saliva Testosterone Increases in Irritable Bowel Syndrome (IBS) Patients Beginning Choir Singing

Start date: May 2006
Phase: N/A
Study type: Interventional

The hypothesis was that a one-year experience of choir singing once a week is more beneficial than group discussions to saliva concentration of testosterone.

NCT ID: NCT00930644 Completed - Clinical trials for Short Bowel Syndrome

Open-Label Study of Teduglutide for Subjects With PN-Dependent Short Bowel Syndrome (SBS)

Start date: September 21, 2009
Phase: Phase 3
Study type: Interventional

This study is a 2-year open label extension study to collect long term efficacy and safety data from patients who have completed the 24-weeks of study drug dosing in CL0600-020.

NCT ID: NCT00930592 Completed - Metabolic Syndrome Clinical Trials

Peds Metabolic Syndrome in Psoriasis

Start date: April 2009
Phase:
Study type: Observational

The objective of this study is to assess whether there is an increased risk of the metabolic syndrome in children with psoriasis compared to children without psoriasis.

NCT ID: NCT00930423 Completed - Clinical trials for Atypical Hemolytic Uraemic Syndrome

Complement Activation During Hemodialysis in Atypical Hemolytic Uraemic Syndrome as Underlying Kidney Disease

Start date: August 2009
Phase:
Study type: Observational

Atypical hemolytic uraemic syndrome is caused by defects in the regulating factors in the alternative pathway of the complement system. Triggering can cause an uncontrolled complement activation with endothelial damage and thrombotic micro-angiopathy, especially in the kidneys. This can result in endstage renal failure. Complement activation during hemodialysis has been described as a result of contact between blood and the dialysis membrane. Our hypothesis is that patients with atypical hemolytic uraemic syndrome have a stronger complement activation during hemodialysis than patients with another underlying kidney disease. This could be a reason to treat patients with endstage renal failure due to atypical hemolytic uraemic syndrome preferentially with peritoneal dialysis instead of hemodialysis.

NCT ID: NCT00930228 Active, not recruiting - Clinical trials for Polycystic Ovary Syndrome

Effect of High Testosterone on Sleep-associated Slowing of Follicular Luteinizing Hormone (LH) Frequency in Polycystic Ovary Syndrome

CRM004
Start date: January 2009
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine whether a testosterone receptor blocker (flutamide) will normalize sleep-wake luteinizing hormone pulse frequency relationships in women with polycystic ovary syndrome.

NCT ID: NCT00929552 Completed - Metabolic Syndrome Clinical Trials

Effect of Fish Oil on Markers of the Metabolic Syndrome in Overweight Adolescent Boys

TeenFisk
Start date: November 2007
Phase: N/A
Study type: Interventional

The aim of the study is to investigate if dietary fish oil has a beneficial effect on blood pressure, insulin sensitivity, blood lipid profile, body composition and metabolic rate in healthy, but slightly overweight, teenage boys. We hypothesized that the n-3 long chain polyunsaturated fatty acids from fish oil might have greater effect during growth and development, as intervention trials studying the effect of fish oil on babies have shown greater effects than in adults.

NCT ID: NCT00929500 Completed - Metabolic Syndrome Clinical Trials

Exercise Program in Women With Metabolic Syndrome

Start date: July 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to test whether a supervised mixed aerobic and strength training (MAST) program is effective in improving overall physical fitness and blood flow in the brain and lowering risk factors of coronary artery disease (CAD) in women with metabolic syndrome.